SCHEMBL19201205

SCHEMBL19201205

CCNS(=O)(=O)CC(=O)NC

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10772839 0.76 ALDH1A1 (0.36) LMNA
SCHEMBL27637969 0.74 LMNA (0.38) MCL1LMNA
SCHEMBL12917023 0.73 LMNA (0.41) MCL1LMNA
SCHEMBL3582797 0.73 ALDH1A1 (0.32)
SCHEMBL15827325 0.73 CA12 (0.43) LMNAMEN1KMT2A
SCHEMBL15945375 0.72 ALDH1A1 (0.44) MCL1LMNA
SCHEMBL24845988 0.71 REN (0.35) LMNA
SCHEMBL3989465 0.70
SCHEMBL14048777 0.70
SCHEMBL8699794 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017132432-A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA VITAE PHARMACEUTICALS, INC. (US) 2017-08-03 WO disclosed